Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2026-01-02 @ 3:33 PM
Study NCT ID:
NCT01266603
Status:
COMPLETED
Last Update Posted:
2020-02-19
First Post:
2010-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-20
First Submit QC Date:
None
Study First Post Date:
2010-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-16
Results First Submit QC Date:
None
Results First Post Date:
2020-02-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-17
Last Update Post Date:
2020-02-19
Last Update Post Date Type:
ACTUAL